IP Library › Assignment 038655/0493
Patent Assignment
Reel/Frame 038655/0493

Security Interest

Recorded: 2016-05-10 Pages: 32
Assignor
SUNESIS PHARMACEUTICALS, INC.
Executed: 2016-03-31
Assignee
WESTERN ALLIANCE BANK
55 ALMADEN BOULEVARD, SUITE 100, SAN JOSE, CALIFORNIA, 95113
Covered Properties (51)
Novel Compounds, Processes for the Preparation Thereof and Anti-Tumor Agents
Patent: 5,817,669 →
Application: 08/765,232 →
Therapeutic Combinations Comprising (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid
Patent: 7,968,565 →
Application: 11/080,102 →
Publication: US 2005/0215583
Methods of Using Sns-595
Patent: 7,989,468 →
Application: 11/080,283 →
Publication: US 2005/0203120
Pharmaceutical Compositions of (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid
Patent: 7,829,577 →
Application: 11/478,765 →
Publication: US 2006/0247267
Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of certain hematologic disorders
Application: 11/890,196 →
Publication: US 2008/0063642
Methods of Using (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid for Treatment of Cancer
Patent: 8,580,814 →
Application: 11/991,349 →
Publication: US 2009/0263393
1,8-Naphthyridine Compounds for the Treatment of Cancer
Patent: 8,124,773 →
Application: 12/304,750 →
Publication: US 2010/0029708
Pharmaceutical Dosage Forms for (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid
Application: 12/376,118 →
Publication: US 2010/0048609
Method of preparing (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
Patent: 8,497,282 →
Application: 12/650,390 →
Publication: US 2010/0203162
Methods of Using (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid in Combination Therapy
Patent: 8,518,872 →
Application: 12/739,139 →
Publication: US 2010/0297142
Methods of Using (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid for Treatment of Antecedent Hematologic Disorders
Application: 12/747,167 →
Publication: US 2011/0008371
Stable SNS-595 Compositions and Methods of Preparation
Patent: 8,586,601 →
Application: 12/875,927 →
Publication: US 2011/0082169
Compounds and Methods for Treatment of Cancer
Patent: 8,470,817 →
Application: 12/912,617 →
Publication: US 2011/0105497
Stable Sns-595 Compositions and Methods of Preparation
Patent: 8,138,202 →
Application: 12/982,785 →
Publication: US 2011/0086876
Sns-595 and Methods of Using the Same
Application: 13/095,111 →
Publication: US 2011/0263524
Sns-595 and Methods of Using the Same
Patent: 8,669,270 →
Application: 13/159,258 →
Publication: US 2011/0312988
Methods of Using Sns-595 for Treatment of Cancer Subjects with Reduced BRCA2 Activity
Application: 13/203,718 →
Publication: US 2012/0148564
1,8-Naphthyridine Compounds for the Treatment of Cancer
Patent: 8,765,954 →
Application: 13/360,558 →
Publication: US 2012/0245198
Methods of Using (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid for Treatment of Antecedent Hematologic Disorders
Application: 13/477,963 →
Publication: US 2013/0102559
Sns-595 and Methods of Using the Same
Patent: 8,822,493 →
Application: 13/794,583 →
Publication: US 2013/0244967
Method of Preparing (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid
Patent: 8,802,719 →
Application: 13/940,157 →
Publication: US 2014/0171660
Methods of Using (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid in Combination Therapy
Application: 13/972,800 →
Publication: US 2014/0205679
Stable Sns-595 Compositions and Methods of Preparation
Patent: 9,469,635 →
Application: 14/055,590 →
Publication: US 2014/0275547
Methods of Using (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid for Treatment of Cancer
Application: 14/056,877 →
Publication: US 2014/0205680
Sns-595 and Methods of Using the Same
Application: 14/171,673 →
Publication: US 2014/0378505
Compounds and Compositions for Treatment of Cancer
Application: 14/320,414 →
Publication: US 2015/0150858
Method of Preparing (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid
Application: 14/329,765 →
Publication: US 2015/0157614
Methods of Using (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid for Treatment of Certain Hematologic Disorders
Application: 14/461,271 →
Publication: US 2015/0190380
Sns-595 and Methods of Using the Same
Patent: 9,980,949 →
Application: 14/462,439 →
Publication: US 2015/0190381
Methods of Using Sns-595 for Treatment of Cancer Subjects with Reduced BRCA2 Activity
Application: 14/476,606 →
Publication: US 2015/0202189
Methods of Using (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid for Treatment of Antecedent Hematologic Disorders
Patent: 9,724,338 →
Application: 14/517,535 →
Publication: US 2015/0250775
Games Controller
Application: 14/948,103 →
Publication: US 2017/0144061
Sns-595 and Methods of Using the Same
Patent: 9,757,363 →
Application: 14/996,025 →
Publication: US 2016/0361302
Method of Preparing (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid
Patent: 9,839,630 →
Application: 15/064,498 →
Publication: US 2017/0035741
Dosing methods, combinations and uses pf SNS-595
Application: 60/553,578 →
Methods of using SNS-595 for treatment of hematologic malignancies
Application: 60/788,927 →
Methods of using SNS-595 for treatment of cancer
Application: 60/789,093 →
Methods of using SNS-595 for treatment of cancer
Application: 60/810,285 →
Compounds and compositions for treatment of cancer
Application: 60/812,835 →
Pharmaceutical dosage forms for (+)-1,4-dihydro-7-(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8,-naphthyridine-3-carboxylic acid
Application: 60/835,148 →
Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-OXO-1(2-thiazolyl)-1-,8-naphthyridine-3-carboxylic acid for treatment of hematologic malignancies
Application: 60/835,239 →
Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphtyridine-3-carboxylic acid for treatment of hematologic malignancies
Application: 60/873,760 →
SNS-595 and methods of using the same
Application: 60/921,500 →
Publication: US 2006/0025437
SNS-595 and methods of using the same
Application: 60/921,501 →
Publication: US 2006/0063795
Methods of Using (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid in Combination Therapy
Application: 60/981,766 →
Methods of using (+)-1, 4-dihydro-7-[3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphtyridine-3-carboxylic acid for treatment of antecedent hematologic disorders
Application: 61/007,229 →
Method of Preparing Voreloxin
Application: 61/141,856 →
Methods of Using Voreloxin for Treatment of Cancer Subjects with Reduced BRCA2 Activity
Application: 61/156,449 →
Methods of Using Voreloxin for Treatment of Cancer Subjects with Reduced BRCA2 Activity
Application: 61/170,013 →
Stable Sns-595 Compositions and Methods of Preparation
Application: 61/240,161 →
Compounds and Methods for Treatment of Cancer
Application: 61/255,039 →
Related Assignments (24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 13, 1996
From: TOMITA, KYOJI; CHIBA, KATSUMI; KASHIMOTO, SHIGEKI; SHIBAMORI, KOH-ICHIRO
To: DAINIPPON PHARMACEUTICAL CO., LTD.
Reel/Frame 008413/0615 →
Assignment of Assignor's Interest Mar 14, 2005
From: ADELMAN, DANIEL C.; SILVERMAN, JEFFREY A.
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 016383/0541 →
Assignment of Assignor's Interest Jun 14, 2005
From: ARKIN, MICHELLE; HYDE, JENNIFER; WALKER, DUNCAN; WRIGHT, JASMIN
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 016706/0201 →
Change of Name Jul 27, 2006
From: DAINIPPON PHARMACEUTICAL CO., LTD
To: DAINIPPON SUMITOMO PHARMA CO., LTD
Reel/Frame 018132/0444 →
Assignment of Assignor's Interest Aug 16, 2006
From: HIGAKI, MASARU; NAKAO, SATOSHI
To: DAINIPPON SUMITOMO PHARMA CO., LTD.; SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 018122/0933 →
Assignment of Assignor's Interest Nov 9, 2007
From: ADELMAN, DANIEL C.; SILVERMAN, JEFFREY A.; MICHELSON, GLENN; SCATENA, CAROLINE DARNE
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 020091/0039 →
Corrective Assignment to Correct the Address of the Assignee Previously Recorded on Reel 020091 Frame 0039. Assignor(S) Hereby Confirms the Assignment of Assignor's Interest.. Feb 21, 2008
From: ADELMAN, DANIEL C.; SILVERMAN, JEFFREY A.; MICHELSON, GLEN; SCATENA, CAROLINE DARNE
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 020542/0441 →
Assignment of Assignor's Interest Feb 5, 2009
From: ADELMAN, DANIEL C.; EVANCHIK, MARC J.; SUDHAKAR, ANANTHA; JACOBS, JEFFREY WILLIAM
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 022212/0660 →
Assignment of Assignor's Interest Jun 18, 2009
From: ADELMAN, DANIEL C.; HYDE, JENNIFER; SILVERMAN, JEFFREY A.; ARKIN, MICHELLE
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 022847/0225 →
Assignment of Assignor's Interest Oct 27, 2009
From: JACOBS, JEFFREY W.
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 023431/0975 →
Assignment of Assignor's Interest Nov 6, 2009
From: WALKER, DUNCAN
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 023481/0296 →
Assignment of Assignor's Interest Feb 16, 2010
From: SUDHAKAR, ANANTHA
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 024001/0591 →
Assignment of Assignor's Interest Apr 12, 2010
From: SYNGENE INTERNATIONAL LTD.
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 024219/0096 →
Assignment of Assignor's Interest Apr 12, 2010
From: SUBRAMANI, TAMILARASAN; RAHUMAN, MOHAMED SHEIK MOHAMED MUJEEBUR; SUBBIAH, RAMAR
To: SYNGENE INTERNATIONAL LTD.
Reel/Frame 024216/0165 →
Assignment of Assignor's Interest Aug 18, 2010
From: SILVERMAN, JEFFREY A.
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 024856/0449 →
Assignment of Assignor's Interest Sep 2, 2010
From: MICHELSON, GLENN
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 024934/0768 →
Assignment of Assignor's Interest Dec 16, 2010
From: SUDHAKAR, ANANTHA
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 025510/0011 →
Assignment of Assignor's Interest Dec 17, 2010
From: SUDHAKAR, ANANTHA; JACOBS, JEFF; HASHASH, AHMAD; RITCHIE, SEAN
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 025520/0455 →
Assignment of Assignor's Interest Dec 5, 2011
From: HAWTIN, RACHAEL E.; FOX, JUDITH A.
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 027328/0209 →
Security Agreement May 7, 2012
From: SUNESIS PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 028169/0528 →
Assignment of Assignor's Interest Jun 24, 2013
From: HIGAKI, MASARU; NAKAO, SATOSHI
To: DAINIPPON SUMITOMO PHARMA CO., LTD.; SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 030672/0088 →
Release of Security Interest Apr 1, 2016
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 038330/0382 →
Change of Name Sep 1, 2016
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 039901/0249 →
Release of Security Interest Nov 5, 2020
From: WESTERN ALLIANCE BANK
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 054335/0429 →